(Day 1, Panel 4) Amgen One Year Out: What Have We Learned?

WATCH PROGRAM

DESCRIPTION

2nd BCLT's Advanced Patent Law Institute

(Day 1, Panel 4) Amgen One Year Out: What Have We Learned?

Occurred May 21, 2024

Event Information | Agenda | Resources

Topical questions to speakers can be sent via their firm biopages or LinkedIn profiles hyperlinked within the agenda and slide deck.

Rapid advancement in life sciences technologies has made keeping up with the legal implications more important than ever.  Join us for the 2nd BCLT Advanced Life Sciences Institute, where you will learn from the experts about cutting-edge issues impacting your life sciences practice.

Our programming will share key insights and best practices related to the rapid rise of AI in the life sciences and new trends for licensing, deals, and life sciences funding models. We will also have experts reviewing key developments in the law (Section 112, obviousness-type double patenting), anti-counterfeiting and patient safety, and the ever-complex interplay of regulatory and IP exclusivities.  Finally, don’t miss our in-depth discussions on future pandemic preparedness and use of trade secrets v. patents for portfolio protection!

 

Speakers:

• Doug Behrens, Covington
• Sabrina Poulos, Goodwin

Moderator:

• Allison Schmitt, BCLT

INFO

• Avail. Until: 11/1/2025
• Course Time:   1:00 PM PT
• Duration:   51 min.
• Program Code:   BCLT0016

This course is available to students for free.